The characterization of the PGRMC1 phosphorylation state and associated function requires further investigation and is important for a better understanding of the involvement of PGRMC1 in increased breast cancer risk in progestin-based hormone therapy. This evidence concerns the gene PGRMC1 and breast carcinoma.